Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We found one specific genetic difference that helps explain why an important gene called polymerase beta, or POLB, which is involved in repairing DNA and prevention of colon cancer, responds more strongly to vitamin D in certain populations.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Lines from a total of 60 participants were included, comprising equal numbers of women (n = 30) and men (n = 30) as well as self-identified Black/African Americans (n = 30) and non-Hispanic Whites (n = 30).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB

Study design awaiting verification · PLOS Genetics · 2026

Original publication title

Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB

David Witonsky; Bharathi Laxman; Hina Usman; Margaret C. Bielski; Kristi M. Lawrence; Sonia S. Kupfer

© 2026 Witonsky et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

We measured genomic responses to active vitamin D, 1α,25-dihydroxyvitamin D (1,25D), in colonic organoids from individuals of African and European ancestry. Given protective effects of 1,25D for gastrointestinal conditions such as colorectal cancer, organoid cultures enabled evaluation of condition-specific responses in relevant target tissue across individuals of diverse ancestries. We found significant alterations in transcriptional and chromatin accessibility responses to 1,25D treatment, including some with ancestry-associated differences, and also elucidated the role of cis-genetic variants on treatment responses. Integration of genomic profiling with genetic mapping found an insertion-deletion variant that explains ancestry-associated differences in 1,25D regulation of POLB, an oxidative DNA repair enzyme involved in colorectal carcinogenesis, which also showed signals of positive natural selection.

These findings highlight the importance of including diverse individuals in functional genomics studies to identify potential drivers of population-level differences relevant for clinical outcomes, and to uncover functional mechanisms that may be obscured by ancestry variation.

Author summary

In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds. Colon health is important for everyone, especially since conditions like colon cancer can be influenced by vitamin D responses. Leveraging an experimental approach in which we treated colonic organoids, also known as “mini-guts”, from people of different backgrounds with active vitamin D, we found that genes and cell structures respond differently to vitamin D, some of which depend on a person’s ancestry.

We discovered that vitamin D changes the activity of many genes and some of these changes are different depending on a person’s ancestry.

We found one specific genetic difference that helps explain why an important gene called polymerase beta, or POLB, which is involved in repairing DNA and prevention of colon cancer, responds more strongly to vitamin D in certain populations. Including people with different backgrounds in genetic research is critical to better understand how treatments like vitamin D might work differently for heterogeneous groups and could improve health care for everyone.

Authors’ abstract

We measured genomic responses to active vitamin D, 1α,25-dihydroxyvitamin D (1,25D), in colonic organoids from individuals of African and European ancestry. Given protective effects of 1,25D for gastrointestinal conditions such as colorectal cancer, organoid cultures enabled evaluation of condition-specific responses in relevant target tissue across individuals of diverse ancestries. We found significant alterations in transcriptional and chromatin accessibility responses to 1,25D treatment, including some with ancestry-associated differences, and also elucidated the role of cis-genetic variants on treatment responses. Integration of genomic profiling with genetic mapping found an insertion-deletion variant that explains ancestry-associated differences in 1,25D regulation of POLB, an oxidative DNA repair enzyme involved in colorectal carcinogenesis, which also showed signals of positive natural selection.

These findings highlight the importance of including diverse individuals in functional genomics studies to identify potential drivers of population-level differences relevant for clinical outcomes, and to uncover functional mechanisms that may be obscured by ancestry variation.

Author summary

In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds. Colon health is important for everyone, especially since conditions like colon cancer can be influenced by vitamin D responses. Leveraging an experimental approach in which we treated colonic organoids, also known as “mini-guts”, from people of different backgrounds with active vitamin D, we found that genes and cell structures respond differently to vitamin D, some of which depend on a person’s ancestry.

We discovered that vitamin D changes the activity of many genes and some of these changes are different depending on a person’s ancestry.

We found one specific genetic difference that helps explain why an important gene called polymerase beta, or POLB, which is involved in repairing DNA and prevention of colon cancer, responds more strongly to vitamin D in certain populations. Including people with different backgrounds in genetic research is critical to better understand how treatments like vitamin D might work differently for heterogeneous groups and could improve health care for everyone.

Publication and source details

Original title: Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB

David Witonsky; Bharathi Laxman; Hina Usman; Margaret C. Bielski; Kristi M. Lawrence; Sonia S. Kupfer

PLOS Genetics · 2026

The authors have declared that no competing interests exist.

* E-mail: skupfer@medicine.bsd.uchicago.edu
© 2026 Witonsky et al2026Witonsky et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/100007316Division of Cancer Prevention, National Cancer Institute CA220329 Kupfer Sonia S. This study was supported by the National Institute of Health grant R01CA220329-01A1 to SSK. The funder had no role in study design, data collection of analysis, decision to publish or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:23:45.451487+00:00

DOI: 10.1371/journal.pgen.1011983 · PMC12810902